Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Iovance Biotherapeutics Inc (IOVA)
Iovance Biotherapeutics Inc (IOVA) Financials

IOVA Iovance Biotherapeutics Inc

7.49

0.03 (0.40%)

24 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-73.754	-56.264	-38.85	-47.865	-46.641	-44.282	-54.935	-61.487
Return on Equity (%)	-75.55	-58.94	-40.407	-51.638	-54.336	-53.554	-70.613	-81.907
Return on Invested Capital (%)	-39.595	-60.16	-42.38	-54.912	-56.446	-59.023	-78.425	-84.879
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-37638.015
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-37345.416
Book Value Per Share	2.681	1.988	3.777	2.296	4.358	3.889	2.621	1.373
Earnings Per Share	-1.644	-1.258	-1.001	-1.517	-1.723	-2.141	-2.076	-1.716
Cash Per Share	1.714	1.987	0.666	0.107	0.447	0.489	1.215	0.444
Working Capital Per Share	2.643	1.905	3.735	2.131	3.858	2.62	2.033	0.763
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-0.037
EBIT Per Share	-0.85	-1.258	-1.001	-1.517	-1.723	-2.141	-2.076	-1.729
EBITDA Per Share	-0.85	-1.258	-1.001	-1.517	-1.723	-2.141	-2.076	-1.729
Free Cash Flow Per Share	-1.635	-1.257	-0.999	-1.473	-1.42	-1.926	-2.018	-1.713

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	62.25M	73.16M	123.42M	126.41M	146.88M	157.01M	187.81M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	157.84M	187.81M	224.36M	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	-15997.762	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	-15800.839	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	2.27B
Price to Earnings Ratio	-5.14
Price to Sales Ratio	1.92k
Price to Cash Ratio	19.87
Price to Book Ratio	3.9
Dividend Yield	-

Share Statistics

Shares Outstanding	304.78M
Average Volume (1 week)	7.9M
Average Volume (1 Month)	5.5M
52 Week Change	-12.19%
52 Week High	18.33
52 Week Low	6.70

More Ratios Coming Soon!

Iovance Biotherapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions